Lundbeck

4 Parkway N Ste 200 , Deerfield, IL 60015

Public
Healthcare & Pharmaceuticals - Pharmaceuticals
around $500M - 1B
around 5K - 10K
(847) 282-1000
847-282-1001


Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 50 years, we have been at the forefront of research within neuroscience. Our key areas of focus are alcohol dependence, Alzheimer's disease, bipolar disorder, depression/anxiety, epilepsy, Huntington's disease, Parkinson's disease, schizophrenia and stroke. An estimated 700 million people worldwide are living with brain disease and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain disease we call this Progress in Mind. Read more at www.lundbeck.com/global/about-us/progress-in-mind. Our approximately 6... (Source: SEC reports)


Competitor - 1/8
Which company is more competitive with Lundbeck?




277 Contacts at this company
Pernille Storm
Director & Head of Global Pricing ...
Olivier Battaglione
Regional Business Director-West ...
Tucker Hatch
Rare Disease Specialist
Mark Milner
Account Manager
Matt Flesch
Executive Director, Product Communications ...
Jeffrey Garnett
Senior Regional Business Director
Brad Montgomery
Regional Business Director
Rachel Johnson
Charlotte, North Carolina | Professional
Nick Olivares, CPA
Accounting Manager

May 8, 2018 17:42:47
DEERFIELD, Ill.--(BUSINESS WIRE)--For the third straight year, Lundbeck US, an affiliate of Danish-based H. Lundbeck A/S, was ranked first in corporate reputation by U.S. [...]

May 8, 2018 17:31:09
DEERFIELD, Ill.--(BUSINESS WIRE)--For the third straight year, Lundbeck US, an affiliate of Danish-based H. Lundbeck A/S, was ranked first in corporate reputation by U.S. [...]

Dec 2, 2017 19:18:32
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck today presented data at the American Epilepsy Society (AES) Annual Meeting in Washington, D.C. that demonstrates that the Refractory  [...]

Dec 2, 2017 17:30:22
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck today presented data at the American Epilepsy Society (AES) Annual Meeting in Washington, D.C. that demonstrates that the Refractory  [...]

Nov 1, 2017 18:06:38
TOKYO & VALBY, Denmark--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announce that the two companies will initiate a third clinical [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.